Rimasia Capital Partners, L.P., Director, Ten Percent Owner at Caladrius Biosciences, holds 2.21M shares in Caladrius Biosciences (Ticker: CLBS). Most recently, Rimasia Capital Partners, L.P. Sold 13,940 shares of Caladrius Biosciences on Jan 02, 2015 for an estimated value of 49.07K.
Rimasia Capital Partners, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Rimasia Capital Partners, L.P.?
The percentage of profitable transactions made by Rimasia Capital Partners, L.P. is 0%.
What is the average return per transaction made by Rimasia Capital Partners, L.P.?
The average return per transaction made by Rimasia Capital Partners, L.P. is -62.00%.
What stocks does Rimasia Capital Partners, L.P. hold?
Rimasia Capital Partners, L.P. holds: CLBS stocks.
What was Rimasia Capital Partners, L.P.’s latest transaction?
Rimasia Capital Partners, L.P. latest transaction was an Informative Sell of 49.07K.
What was Rimasia Capital Partners, L.P.'s most profitable transaction?
Rimasia Capital Partners, L.P.’s most profitable transaction was an Informative Buy of CLBS stock on February 22, 2010. The return on the trade was -4.90%.
What is Rimasia Capital Partners, L.P.'s role in Caladrius Biosciences?
Rimasia Capital Partners, L.P.'s role in Caladrius Biosciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.